Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Classement en actions #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Prix de l'action
$2.10
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$104.43M
Changement (1 jour)
-2.10%
Changement (1 an)
-
Pays
US
Échange Polaryx Therapeutics, Inc. Common Stock (PLYX)

Catégorie

Le prix PLYX avec la capitalisation boursière de B
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
PLYX
$2.10
Capitalisation boursière de Polaryx Therapeutics, Inc. Common Stock(PLYX)
Capitalisation boursière: $104.43M
En August 2026, Polaryx Therapeutics, Inc. Common Stock a une capitalisation boursière de $104.43M. Cela fait de Polaryx Therapeutics, Inc. Common Stock la 21586th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Polaryx Therapeutics, Inc. Common Stock du 2026 au 2026
PLYX par rapport au top 5 des plus populaires stocks
Prix pour PLYX L’actif B La capitalisation boursière de B Résultats
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$104,550 $104.43M
$5.211T +4,990,345.79%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$91,216.26 $104.43M
$4.547T +4,353,897.93%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$83,507.08 $104.43M
$4.162T +3,985,918.08%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$72,078.12 $104.43M
$3.593T +3,440,383.24%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$56,029.90 $104.43M
$2.793T +2,674,358.16%